IMARC Group has recently released a new research study titled “United States Radiotherapy Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2026-2034”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.

United States Radiotherapy Market Outlook 2034: Opportunities for Oncology Technology and Care Providers

The United States radiotherapy market size reached USD 1.80 Billion in 2025 and is projected to reach USD 2.70 Billion by 2034, exhibiting a compound annual growth rate (CAGR) of 4.04% during 2026-2034. Rising cancer incidence, more sophisticated radiotherapy machines, significant technological innovation, flourishing healthcare expenditure and wider adoption of minimally invasive, precisely targeted treatments are shaping United States radiotherapy market share for equipment makers and care providers. For manufacturers, hospitals and investors, understanding the dynamics of this market is crucial.

Key Market Statistics at a Glance

Base Year:  2025

Historical Years:  2020–2025

Forecast Period:  2026–2034

Market Size (2025):  USD 1.80 Billion

Projected Size (2034):  USD 2.70 Billion

Growth Rate:  CAGR of 4.04% (2026-2034)

Explore Growth Opportunities in the United States Radiotherapy Market Grab Your Sample Report for Evaluation: https://www.imarcgroup.com/united-states-radiotherapy-market/requestsample

How Technology and Precision Oncology Are Transforming the United States Radiotherapy Market

Rapid technological progress is improving treatment precision and efficacy across American cancer care. Advanced imaging, dose calculation algorithms and delivery methods increase tumor dose accuracy while reducing normal tissue toxicity, leading to better cancer management and quality of life. These advances are among the most visible United States radiotherapy market trends, encouraging healthcare providers to adopt new technologies.

Key Technology Trends:

• Proton Therapy and Stereotactic Radiosurgery: These techniques deliver higher precision in targeting tumors while minimizing damage to surrounding tissues.
• AI in Planning and Delivery: Artificial intelligence is enhancing treatment accuracy and personalization in radiotherapy planning and delivery.
• Advanced Imaging and Image-Guided Delivery: Integration of PET and CT imaging with IMRT, IGRT and multileaf collimators supports precise tumor delineation and dose estimation.

United States Radiotherapy Market: Key Growth Drivers and Strategic Insights for Businesses

Several key drivers are fueling United States radiotherapy market growth, and understanding them is essential for businesses looking to invest in equipment, services or treatment facilities.

Key Growth Drivers:

1. Rising Incidence of Cancer: According to the National Cancer Institute, an estimated 2,001,140 new cancer cases were projected to be diagnosed in the U.S. in 2024, with 611,720 deaths and an annual incidence rate of 440.5 per 100,000 people. This burden sustains United States radiotherapy market demand for effective treatment options.
2. Technological Advancements: Techniques such as 3D conformal radiotherapy, IMRT, IGRT, stereotactic radiotherapy and particle therapy are improving survival and treatment personalization, shaping United States radiotherapy market trends toward precision care.
3. Healthcare Spending and Reimbursement: Higher healthcare expenditure and favorable reimbursement policies make advanced treatments more accessible; Medicare Part B, for example, covers outpatient radiation therapy. Government support for cancer research further encourages adoption of state-of-the-art systems, supporting United States radiotherapy market growth.

Strategic Insights:

• Invest in Precision Technologies: Providers and vendors offering proton therapy, stereotactic body radiation therapy and AI-enabled planning can strengthen United States radiotherapy market share.
• Expand Outpatient Access: Ambulatory radiotherapy centers and telemedicine can reach underserved areas and meet United States radiotherapy market demand outside major hospitals.
• Prioritize Training and Cost Management: High equipment costs and the need for extensive professional training remain challenges; addressing them, along with reimbursement consistency, can sustain United States radiotherapy market growth.

Why Healthcare Providers Are Investing in Advanced Radiotherapy in the United States

Hospitals, research institutes and radiotherapy centers across the country are investing in advanced systems as cancer cases rise and treatment standards evolve. A detailed United States radiotherapy market analysis shows that precision, patient outcomes and access are now central to purchasing decisions, reinforcing United States radiotherapy market demand for next-generation platforms.

Reasons for Investment:

• Better Clinical Outcomes: Precision targeting improves tumor control, reduces damage to healthy tissue and supports higher survival rates.
• Patient Convenience and Lower Costs: Specialized outpatient centers offer shorter treatment durations and minimal hospital stays, making advanced care more accessible.
• Favorable Funding Environment: Public insurance coverage, rising healthcare spending and a record 93% insured share of the population support access to advanced treatments.

United States Radiotherapy Market Segmentation:

IMARC Group’s United States radiotherapy market analysis covers each segment with forecasts for 2026-2034, showing how every category contributes to the overall United States radiotherapy market size and United States radiotherapy market share.

Type Insights:

• External Beam Radiation Therapy
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Image-Guided Radiation Therapy (IGRT)
  • Tomotherapy
  • Stereotactic Radiosurgery
  • Stereotactic Body Radiation Therapy
  • Proton Therapy
  • 3D Conformal Radiotherapy (3D CRT)
  • Volumetric Modulated Arc Therapy (VMAT)
• Internal Radiation Therapy/Brachytherapy
• Systemic Radiation Therapy

Application Insights:

• Skin and Lip Cancer
• Head and Neck Cancer
• Breast Cancer
• Prostate Cancer
• Cervical Cancer
• Lung Cancer
• Others

End User Insights:

• Hospitals
• Cancer Research Institutes
• Ambulatory and Radiotherapy Centers

Regional Insights:

• Northeast
• Midwest
• South
• West

Speak to an Analyst: https://www.imarcgroup.com/request?type=report&id=19082&flag=C

Leading Companies in the United States Radiotherapy Market

Competition is shaped by firms offering proton therapy, stereotactic radiosurgery and AI-driven treatment planning, supported by partnerships and acquisitions. A focused United States radiotherapy market analysis of these players, along with the latest United States radiotherapy market trends, helps stakeholders benchmark their strategies.

• Varian Medical Systems (a Siemens Healthineers company) – Supplies linear accelerators, treatment planning software and image-guided radiotherapy systems for cancer centers and hospitals.
• Elekta AB – Radiation therapy leader providing precision treatment and imaging solutions, expanding access through collaboration with GE HealthCare.
• Accuray Incorporated – Develops advanced radiation therapy platforms, including tomotherapy systems, aimed at expanding cancer treatment options.
• GE HealthCare – Offers imaging, diagnostics and digital solutions that complement radiation therapy delivery in hospitals.
• RefleXion Medical – Developer of the X1 platform with SCINTIX biology-guided radiotherapy for early and late-stage solid tumors.
• IntraOp Medical Corporation – Provider of electron-based radiotherapy technology, including work on FLASH radiotherapy trials for skin cancer.

Author IMARC Group

IMARC Group is a leading global management consulting firm providing comprehensive market research, feasibility studies, and strategic advisory services. The firm supports organizations worldwide in identifying growth opportunities, mitigating risks, and making informed business decisions across industries.

Contact Us
IMARC Group
Email: sales@imarcgroup.com
United States: +1-201-971-6302